Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 481

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Delivery of peptides and proteins through the blood–brain barrier

Bickel, Ulrich, Yoshikawa, Takayoshi, Pardridge, William M.·2001·Advanced Drug Delivery Reviews
DOI 10.1016/s0169-409x(00)00139-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(00)00139-3

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 131

  1. De Bault, 1980, Gamma-glutamyl transpeptidase in isolated brain endothelial cells: Induction by glial cells in vitro, Science, 207, 653, 10.1126/science.6101511 · DOI · Paper page
  2. Cordon-Cardo, 1989, Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites, Proc. Natl. Acad. Sci. USA, 86, 695, 10.1073/pnas.86.2.695 · DOI · Paper page
  3. Mueckler, 1985, Sequence and structure of a human glucose transporter, Science, 229, 941, 10.1126/science.3839598 · DOI · Paper page
  4. Birnbaum, 1986, Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein, Proc. Natl. Acad. Sci. USA, 83, 5784, 10.1073/pnas.83.16.5784 · DOI · Paper page
  5. Pardridge, 1990, Comparison of in vitro and in vivo models of drug transcytosis through the blood–brain barrier, J. Pharmacol. Exp. Ther., 253, 884
  6. Duvernoy, 1983, The vascularization of the human cerebellar cortex, Brain Res. Bull., 11, 419, 10.1016/0361-9230(83)90116-8 · DOI · Paper page
  7. Brightman, 1977, Morphology of blood–brain interfaces, Exp. Eye Res., 25, 1, 10.1016/S0014-4835(77)80008-0 · DOI · Paper page
  8. Shapiro, 1975, Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections, N. Engl. J. Med., 293, 161, 10.1056/NEJM197507242930402 · DOI · Paper page
  9. Blasberg, 1975, Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion, J. Pharmacol. Exp. Ther., 195, 73
  10. Harbaugh, 1989, Nerve growth factor as a potential treatment in Alzheimer’s disease, Biomed. Pharmacother., 43, 483, 10.1016/0753-3322(89)90108-X · doi:10.1016/0753-3322(89)90108-x
  11. Munsat, 1992, Intrathecal thyrotropin releasing hormone does not alter the progressive course of ALS, Neurology, 42, 1049, 10.1212/WNL.42.5.1049 · doi:10.1212/wnl.42.5.1049
  12. Caroscio, 1986, A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis, Neurology, 36, 141, 10.1212/WNL.36.2.141 · DOI
  13. Rieselbach, 1962, Subarachnoid distribution of drugs after lumbar injection, N. Engl. J. Med., 267, 1273, 10.1056/NEJM196212202672502 · DOI · Paper page
  14. Oldendorf, 1970, Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard, Brain Res., 24, 372, 10.1016/0006-8993(70)90123-X · DOI · Paper page
  15. Pardridge, 1988, Recent advances in blood–brain barrier transport, Annu. Rev. Pharmacol. Toxicol., 28, 25, 10.1146/annurev.pa.28.040188.000325 · DOI · Paper page
  16. Pardridge, 1984, Tracer kinetic model of blood–brain barrier transport of plasma protein-bound ligands, J. Clin. Invest., 74, 745, 10.1172/JCI111490 · DOI
  17. Zlokovic, 1986, Measurement of solute transport across the blood–brain barrier in the perfused guinea pig brain: Method and application to N-methyl-α-aminoisobutyric acid, J. Neurochem., 46, 1444, 10.1111/j.1471-4159.1986.tb01760.x · DOI
  18. Zlokovic, 1987, Transport of leucine-enkephalin across the blood–brain barrier in the perfused guinea pig brain, J. Neurochem., 49, 310, 10.1111/j.1471-4159.1987.tb03431.x · DOI
  19. Zlokovic, 1988, Slow penetration of thyrotropin-releasing hormone across the blood–brain barrier of an in situ perfused guinea pig brain, J. Neurochem., 51, 252, 10.1111/j.1471-4159.1988.tb04864.x · DOI
  20. Zlokovic, 1989, Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood–brain barrier of an in situ perfused guinea-pig brain, J. Neurochem., 53, 1333, 10.1111/j.1471-4159.1989.tb08522.x · DOI
  21. Takasato, 1984, An in situ brain perfusion technique to study cerebrovascular transport in the rat, Am. J. Physiol., 247, H484
  22. Fenstermacher, 1981, Methods for quantifying the transport of drugs across brain barrier systems, Pharmacol. Ther., 14, 217, 10.1016/0163-7258(81)90062-0 · DOI · Paper page
  23. Patlak, 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab., 3, 1, 10.1038/jcbfm.1983.1 · DOI · Paper page
  24. Blasberg, 1983, Transport of α-aminoisobutyric acid across brain capillary and cellular membranes, J. Cereb. Blood Flow Metab., 3, 8, 10.1038/jcbfm.1983.2 · DOI · Paper page
  25. Pardridge, 1990, β-endorphin chimeric peptides: Transport through the blood–brain barrier in vivo and cleavage of disulfide linkage by brain, Endocrinology, 126, 977, 10.1210/endo-126-2-977 · DOI
  26. Churchill, 1987, Metabolism of opioid peptides by cerebral microvascular aminopeptidase M, Biochim. Biophys. Acta, 923, 35, 10.1016/0304-4165(87)90122-X · doi:10.1016/0304-4165(87)90122-x
  27. Solhonne, 1987, Major localization of aminopeptidase M in rat brain microvessels, Neuroscience, 22, 225, 10.1016/0306-4522(87)90212-0 · DOI
  28. Zlokovic, 1985, Blood–brain barrier permeability to leucine-enkephalin, d-alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine), Brain Res., 336, 125, 10.1016/0006-8993(85)90423-8 · DOI · Paper page
  29. Triguero, 1990, Capillary depletion method for quantifying blood–brain barrier transcytosis of circulating peptides and plasma proteins, J. Neurochem., 54, 1882, 10.1111/j.1471-4159.1990.tb04886.x · DOI · Paper page
  30. Duffy, 1987, Blood–brain barrier transcytosis of insulin in developing rabbits, Brain Res., 420, 32, 10.1016/0006-8993(87)90236-8 · DOI · Paper page
  31. Broadwell, 1988, Transcytotic pathway for blood-borne protein through the blood–brain barrier, Proc. Natl. Acad. Sci. USA, 85, 632, 10.1073/pnas.85.2.632 · DOI · Paper page
  32. Joo, 1985, The blood–brain barrier in vitro: Ten years of research on microvessels isolated from the brain, Neurochem. Int., 7, 1, 10.1016/0197-0186(85)90002-6 · DOI
  33. Lasbennes, 1983, Capacity for energy metabolism in microvessels isolated from rat brain, Neurochem. Res., 9, 1, 10.1007/BF00967654 · DOI
  34. van Houten, 1979, Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography, Endocrinology, 105, 666, 10.1210/endo-105-3-666 · DOI · Paper page
  35. Frank, 1981, A direct in vitro demonstration of insulin binding to isolated brain microvessels, Diabetes, 30, 757, 10.2337/diabetes.30.9.757 · DOI
  36. Pardridge, 1985, Human blood–brain barrier insulin receptor, J. Neurochem., 44, 1771, 10.1111/j.1471-4159.1985.tb07167.x · DOI · Paper page
  37. Duffy, 1988, Human blood–brain barrier insulin-like growth factor receptor, Metabolism, 37, 136, 10.1016/S0026-0495(98)90007-5 · DOI · Paper page
  38. Frank, 1986, Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels, Diabetes, 35, 654, 10.2337/diabetes.35.6.654 · DOI
  39. Speth, 1985, Angiotensin II receptor binding sites in brain microvessels, Proc. Natl. Acad. Sci. USA, 82, 6340, 10.1073/pnas.82.18.6340 · DOI
  40. Chabrier, 1987, Specific binding of atrial natriuretic factor in brain microvessels, Proc. Natl. Acad. Sci. USA, 84, 2078, 10.1073/pnas.84.7.2078 · DOI
  41. Okazaki, 1990, Atrial natriuretic peptide receptors in cerebral microvessels and choroid plexus of spontaneously hypertensive rats, Brain Res., 518, 292, 10.1016/0006-8993(90)90984-J · DOI
  42. Jefland, 1991, Brain and atrial natriuretic peptide bind to common receptors in brain capillary endothelial cells, Am. J. Physiol., 261, E183
  43. Hashimoto, 1991, Action site of circulating interleukin-1 on the rabbit brain, Brain Res., 540, 217, 10.1016/0006-8993(91)90510-3 · DOI
  44. Fishman, 1987, Receptor-mediated transcytosis of transferrin across the blood–brain barrier, J. Neurosci. Res., 18, 299, 10.1002/jnr.490180206 · DOI · Paper page
  45. Taylor, 1990, Developmental changes in transferrin and iron uptake by the brain in the rat, Dev. Brain Res., 55, 35, 10.1016/0165-3806(90)90103-6 · DOI · Paper page
  46. Grasso, 1987, Transglutaminase activity in bovine calf testicular membranes: Evidence for a possible role in the interaction of follicle-stimulating hormone with its receptor, Endocrinology, 121, 459, 10.1210/endo-121-2-459 · DOI
  47. Gex-Fabry, 1984, Receptor-mediated endocytosis: A model and its implications for experimental analysis, Am. J. Physiol., 247, R768
  48. Verner, 1988, Protein translocation across membranes, Science, 241, 1307, 10.1126/science.2842866 · DOI · Paper page
  49. Lund, 1990, Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization, J. Biol. Chem., 265, 15713, 10.1016/S0021-9258(18)55456-9 · DOI · Paper page
  50. Clarke, 1985, Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes, J. Biol. Chem., 260, 128, 10.1016/S0021-9258(18)89703-4 · DOI
  51. Solenski, 1985, Insulin binding and vesicular ingestion in capillary endothelium, J. Cell. Physiol., 124, 87, 10.1002/jcp.1041240115 · doi:10.1002/jcp.1041240115
  52. Willingham, 1984, Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells, Proc. Natl. Acad. Sci. USA, 81, 175, 10.1073/pnas.81.1.175 · DOI · Paper page
  53. Ahnert-Hilger, 1985, Minimal requirements for exocytosis, J. Biol. Chem., 260, 12730, 10.1016/S0021-9258(17)38936-6 · DOI
  54. McAbee, 1987, ATP depletion causes a reversible redistribution and inactivation of a subpopulation of galactosyl receptors in isolated rat hepatocytes, J. Biol. Chem., 260, 128
  55. Vilmart-Seuwen, 1986, ATP keeps exocytosis sites in a primed state but is not required for membrane fusion: An analysis with Paramecium cells in vivo and in vitro, J. Cell Biol., 103, 1279, 10.1083/jcb.103.4.1279 · DOI
  56. Almers, 1990, Exocytosis, Annu. Rev. Physiol., 52, 607, 10.1146/annurev.ph.52.030190.003135 · DOI · Paper page
  57. Pardridge, 1985, Blood–brain barrier protein phosphorylation and dephosphorylation, J. Neurochem., 45, 1141, 10.1111/j.1471-4159.1985.tb05534.x · DOI
  58. Gonatas, 1984, Endosomes and Golgi vesicles in adsorptive and fluid phase endocytosis, J. Cell Biol., 99, 1379, 10.1083/jcb.99.4.1379 · DOI
  59. Nevo, 1955, Interaction of basic polyamino acids with the red blood cell, Biochim. Biophys. Acta, 17, 536, 10.1016/0006-3002(55)90416-9 · doi:10.1016/0006-3002(55)90416-9
  60. Skutelsky, 1976, Redistribution of surface anionic sites on the luminal front of blood vessel endothelium after interaction with polycationic ligand, J. Cell. Biol., 71, 232, 10.1083/jcb.71.1.232 · DOI
  61. Vorbrodt, 1989, Ultracytochemical characterization of anionic sites in the wall of brain capillaries, J. Neurocytol., 18, 359, 10.1007/BF01190839 · DOI
  62. Basu, 1976, Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts, Proc. Natl. Acad. Sci. USA, 73, 3178, 10.1073/pnas.73.9.3178 · DOI · Paper page
  63. Shen, 1978, Conjugation of poly-l-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins, Proc. Natl. Acad. Sci. USA, 75, 1872, 10.1073/pnas.75.4.1872 · DOI · Paper page
  64. Griffin, 1982, Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis, J. Clin. Invest., 70, 289, 10.1172/JCI110616 · DOI
  65. Terasaki, 1989, Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, e-2078, into the blood–brain barrier, J. Pharmacol. Exp. Ther, 251, 351
  66. Terasaki, 1991, In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood–brain barrier: An application of brain microdialysis, Pharm. Res., 8, 815, 10.1023/A:1015882924470 · DOI
  67. Shimura, 1991, Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood brain barrier, J. Pharmacol. Exp. Ther., 258, 459
  68. Peters, 1985, Serum albumin. Adv. Protein Chem., 17, 161, 10.1016/S0065-3233(08)60065-0 · DOI · Paper page
  69. Kumagai, 1987, Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood–brain barrier transport, J. Biol. Chem., 262, 15214, 10.1016/S0021-9258(18)48160-4 · DOI · Paper page
  70. Pardridge, 1990, Evaluation of cationized rat albumin as a potential blood–brain barrier drug transport vector, J. Pharmacol. Exp. Ther., 255, 893
  71. Bergmann, 1984, Plasma clearance, tissue distribution and catabolism of cationized albumins with increasing isoelectric points in the rat, Clin. Sci., 67, 35, 10.1042/cs0670035 · DOI
  72. Pardridge, 1989, Transport of histone through the blood–brain barrier, J. Pharmacol. Exp. Ther., 251, 821
  73. Hardebo, 1985, Endothelial negative surface charge areas and blood–brain barrier function, Acta Physiol. Scand., 125, 495, 10.1111/j.1748-1716.1985.tb07746.x · DOI
  74. Nagy, 1983, Charge-related alterations of the cerebral endothelium, Lab. Invest., 49, 662
  75. Strausbaugh, 1987, Intracarotid infusions of protamine sulfate disrupt the blood–brain barrier of rabbits, Brain Res., 409, 221, 10.1016/0006-8993(87)90705-0 · DOI
  76. Vehaskari, 1984, The effects of polycations on vascular permeability in the rat, J. Clin. Invest., 73, 1053, 10.1172/JCI111290 · DOI
  77. Adler, 1983, Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit, J. Clin. Invest., 71, 487, 10.1172/JCI110793 · DOI
  78. Huang, 1984, In situ formation of immune complexes in the choroid plexus of rats by sequential injection of a cationized antigen and unaltered antibodies, J. Neuropathol. Exp. Neurol., 43, 489, 10.1097/00005072-198409000-00004 · DOI
  79. Nell, 1988, Frequency and specificity of protamine antibodies in diabetic and control subjects, Diabetes, 37, 172, 10.2337/diabetes.37.2.172 · doi:10.2337/diabetes.37.2.172
  80. Muckerheide, 1987, Cationization of protein antigens, J. Immunol., 138, 833, 10.4049/jimmunol.138.3.833 · DOI
  81. Triguero, 1989, Blood–brain barrier transport of cationized immunoglobulin G. Enhanced delivery compared to native protein, Proc. Natl. Acad. Sci. USA, 86, 4761, 10.1073/pnas.86.12.4761 · DOI · Paper page
  82. Pardridge, 1985, Absence of albumin receptor on brain capillaries in vivo or in vitro, Am. J. Physiol., 249, E264
  83. Triguero, 1991, Cationization of immunoglobulin G results in enhanced organ uptake of the protein following intravenous administration in rats and primate, J. Pharmacol. Exp. Ther., 258, 186
  84. Gauthier, 1982, Effect of cationized antibodies in preformed immune complexes on deposition and persistence in renal glomeruli, J. Exp. Med., 156, 766, 10.1084/jem.156.3.766 · DOI
  85. Fujii, 1990, Structural heterogeneity of sugar chains in immunoglobulin G, J. Biol. Chem., 265, 6009, 10.1016/S0021-9258(19)39283-X · DOI
  86. Rodwell, 1986, Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations, Proc. Natl. Acad. Sci. USA, 83, 2632, 10.1073/pnas.83.8.2632 · DOI
  87. Morrison, 1988, Production and characterization of genetically engineered antibody molecules, Clin. Chem., 34, 1668, 10.1093/clinchem/34.9.1668 · doi:10.1093/clinchem/34.9.1668
  88. Morrison, 1984, Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. USA, 81, 6851, 10.1073/pnas.81.21.6851 · DOI · Paper page
  89. Mathieson, 1990, Monoclonal-antibody therapy in systemic vasculitis, N. Engl. J. Med., 323, 250, 10.1056/NEJM199007263230407 · DOI · Paper page
  90. Abuchowski, 1977, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem., 252, 3578, 10.1016/S0021-9258(17)40291-2 · DOI · Paper page
  91. Abuchowski, 1977, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase, J. Biol. Chem., 252, 3582, 10.1016/S0021-9258(17)40292-4 · DOI · Paper page
  92. Pool, 1990, ‘Hairy enzymes’ stay in blood, Science, 248, 305, 10.1126/science.2326644 · doi:10.1126/science.2326644
  93. Giddings, 1985, Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues, Diabetologia, 28, 343, 10.1007/BF00283141 · DOI
  94. Baskin, 1983, Regional concentrations of insulin in rat brain, Endocrinology, 112, 898, 10.1210/endo-112-3-898 · DOI · Paper page
  95. Frank, 1985, Enhanced insulin binding to blood–brain barrier in vivo and to brain microvessels in vitro in newborn rabbits, Diabetes, 34, 728, 10.2337/diabetes.34.8.728 · DOI
  96. Havrankova, 1979, Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents, J. Clin. Invest., 64, 636, 10.1172/JCI109504 · DOI · Paper page
  97. Frank, 1986, Insulin binding to the blood–brain barrier in the streptozotocin diabetic rat, J. Neurochem., 47, 405, 10.1111/j.1471-4159.1986.tb04516.x · DOI
  98. Dahms, 1989, Mannose-6-phosphate receptors and lysosomal enzyme targeting, J. Biol. Chem., 264, 12115, 10.1016/S0021-9258(18)63825-6 · DOI · Paper page
  99. Rosenfeld, 1987, Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood–brain barrier, Biochem. Biophys. Res. Commun., 149, 159, 10.1016/0006-291X(87)91618-4 · DOI
  100. Braulke, 1990, Insulin-like growth factors I and II stimulate endocytosis but do not affect sorting of lysosomal enzymes in human fibroblasts, J. Biol. Chem., 265, 6650, 10.1016/S0021-9258(19)39199-9 · DOI
  101. Kovacina, 1989, Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor, Biochem. Biophys. Res. Commun., 160, 393, 10.1016/0006-291X(89)91669-0 · DOI
  102. Werther, 1990, Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization-relationship to IGF-I receptors, Molec. Endocrinol., 4, 773, 10.1210/mend-4-5-773 · DOI
  103. Haselbacher, 1985, Insulin-like growth factor II (IGF II) in human brain: Regional distribution of IGF II and of higher molecular mass forms, Proc. Natl. Acad. Sci. USA, 82, 2153, 10.1073/pnas.82.7.2153 · DOI · Paper page
  104. Ocrant, 1990, Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system, Endocrinology, 127, 1260, 10.1210/endo-127-3-1260 · DOI
  105. Cascieri, 1988, Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins, Endocrinology, 123, 373, 10.1210/endo-123-1-373 · DOI
  106. Clemmons, 1990, Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity, J. Biol. Chem., 265, 12210, 10.1016/S0021-9258(19)38332-2 · DOI
  107. De Vroede, 1985, Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor, Proc. Natl. Acad. Sci. USA, 82, 3010, 10.1073/pnas.82.9.3010 · doi:10.1073/pnas.82.9.3010
  108. Huebers, 1987, The physiology of transferrin and transferrin receptors, Physiol. Rev., 67, 520, 10.1152/physrev.1987.67.2.520 · DOI · Paper page
  109. Jing, 1990, Nonacylated human transferrin receptors are rapidly internalized and mediate iron uptake, J. Biol. Chem., 265, 11555, 10.1016/S0021-9258(19)38433-9 · DOI
  110. Alvarez, 1990, Inhibition of the receptor-mediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic acid, J. Biol. Chem., 265, 16644, 10.1016/S0021-9258(17)46270-3 · DOI
  111. Pardridge, 1987, Human blood–brain barrier transferrin receptor, Metabolism, 36, 892, 10.1016/0026-0495(87)90099-0 · DOI · Paper page
  112. Seligman, 1983, Structure and function of the transferrin receptor, Prog. Hematol., 13, 131
  113. Friden, 1991, Antitransferrin receptor antibody and antibody–drug conjugates cross the blood–brain barrier, Proc. Natl. Acad. Sci. USA, 88, 4771, 10.1073/pnas.88.11.4771 · DOI · Paper page
  114. Pardridge, 1991, Selective transport of an anti-transferrin receptor antibody through the blood–brain barrier in vivo, J. Pharmacol. Exp. Ther., 259, 66
  115. Letvin, 1986, In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates, J. Clin. Invest, 77, 977, 10.1172/JCI112399 · DOI
  116. Worrell, 1986, Fate of an antibody-ricin A chain conjugate administered to normal rats, Biochem. Pharmacol., 35, 417, 10.1016/0006-2952(86)90214-5 · doi:10.1016/0006-2952(86)90214-5
  117. W.M. Pardridge, C.L. Farrell, Localization of blood–brain barrier-specific antibodies with immunogold-silver enhancement methodology, J. Histotechnol. (1993), in press. · DOI
  118. Broadwell, 1989, Transcytosis of macromolecules through the blood–brain barrier: A cell biological perspective and critical appraisal, Acta Neuropathol., 79, 117, 10.1007/BF00294368 · DOI · Paper page
  119. Pardridge, 1992, Transport of recombinant CD4 through the rat blood brain barrier, J. Pharmacol. Exp. Ther., 261, 1175
  120. Pardridge, 1987, Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood–brain barrier, Biochem. Biophys. Res. Commun., 146, 307, 10.1016/0006-291X(87)90726-1 · DOI
  121. Yoshikawa, 1992, Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor, J. Pharmacol. Exp. Ther., 263, 897
  122. W.M. Pardridge, R.J. Boado, J.L. Buciak, Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin–biotin system, Drug Targeting Delivery (1993), in press. · DOI
  123. Green, 1990, Avidin and streptavidin, Methods Enzymol., 184, 51, 10.1016/0076-6879(90)84259-J · DOI · Paper page
  124. Pardridge, 1991, Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein, FEBS Lett., 288, 30, 10.1016/0014-5793(91)80996-G · DOI
  125. Riddles, 1979, Ellman’s reagent: 5,5′-dithiobis(2-nitrobenzoic acid) — a reexamination, Anal. Biochem., 94, 75, 10.1016/0003-2697(79)90792-9 · DOI · Paper page
  126. Bewley, 1983, Evidence for tertiary structure in aqueous solutions of human β-endorphin as shown by difference absorption spectroscopy, Biochemistry, 22, 2671, 10.1021/bi00280a013 · doi:10.1021/bi00280a013
  127. Yaksh, 1987, Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat, J. Gereb. Blood Flow Metab., 7, 315, 10.1038/jcbfm.1987.69 · DOI
  128. McCulloch, 1980, Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide, Am. J. Physiol., 238, H449
  129. Bickel, 1993, Pharmacologic effects in vivo in brain by vector-mediated delivery of peptides, Proc. Natl. Acad. Sci. USA, 90, 2618, 10.1073/pnas.90.7.2618 · DOI
  130. Andersson, 1991, The preparation of biotinyl-ε-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor, FEBS Lett., 282, 35, 10.1016/0014-5793(91)80439-A · doi:10.1016/0014-5793(91)80439-a
  131. Huffman, 1986, Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat, Endocrinology, 118, 550, 10.1210/endo-118-2-550 · doi:10.1210/endo-118-2-550

Cited by

See all 481

Metadata

Authors
Bickel, U., Yoshikawa, T., & Pardridge, W. M.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2001-03
Volume
46
Issue
1-3
Pages
247-279
ISSN
0169-409X (ISSN-L)
DOI
10.1016/s0169-409x(00)00139-3
OpenAlex
W2095512576
Cited by
481
References
3
FWCI
0.87
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Delivery of peptides and proteins through the blood–brain barrier. https://app.cochat.ai/papers/10.1016/s0169-409x(00)00139-3
The paper
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001). Delivery of peptides and proteins through the blood–brain barrier. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(00)00139-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.